Clik here to view.
First Annual Biotechnical Design Competition Finals in Barcelona
Thursday, September 21st 2017 at 5:09pm UTC Joint European and US teams present designs at the 4th European Congress of Applied Biotechnology, October 1-5, 2017 WOBURN, Mass.–(BUSINESS WIRE)– Tiffany...
View ArticleClik here to view.
Amylyx Pharmaceuticals Receives FDA Orphan Drug Designation for AMX0035 for...
Tuesday, September 19th 2017 at 1:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Amylyx Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug...
View ArticleClik here to view.
F-Prime Capital Announces Joshua Grass as New Entrepreneur-in-Residence
Wednesday, September 20th 2017 at 11:30am UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– F-Prime Capital, a global venture capital firm focused on investments in healthcare and technology, today announced that...
View ArticleClik here to view.
Lysogene Holds First Parent Advisory Board in MPS IIIA
Thursday, September 21st 2017 at 5:00am UTC First Advisory Board comprised of parents of children with MPS IIIA, a rare and lethal disease of the central nervous system (CNS) Advisory Board provides...
View ArticleClik here to view.
Agilent Technologies Joins with LabCentral to Help Advance Scientific Discovery
Tuesday, September 19th 2017 at 3:00pm UTC Strategic Sponsorship Will Provide Innovative Technology and Nurture Promising Biotechnology Startup SANTA CLARA, Calif. & CAMBRIDGE, Mass.–(BUSINESS...
View ArticleClik here to view.
Gene Editing Technology Developer Awarded $500,000 Lemelson-MIT Prize
Tuesday, September 19th 2017 at 1:00pm UTC Feng Zhang Recognized for Commitment to Invention, Collaboration and Mentorship CAMBRIDGE, Mass.–(BUSINESS WIRE)– Dr. Feng Zhang, a pioneer of the...
View ArticleClik here to view.
PAREXEL International Receives Shareholder Approval for Proposed Acquisition...
Monday, September 18th 2017 at 1:00pm UTC BOSTON–(BUSINESS WIRE)– PAREXEL International Corporation (NASDAQ: PRXL) (« PAREXEL » or the « Company »), a leading global biopharmaceutical services...
View ArticleClik here to view.
Eleven Biotherapeutics Announces Completion of Vicinium Manufacturing for...
Friday, September 22nd 2017 at 12:00pm UTC — Topline Three-Month Data from Phase 3 Registration Trial Expected in Mid-2018 — CAMBRIDGE, Mass.–(BUSINESS WIRE)– Eleven Biotherapeutics, Inc....
View ArticleClik here to view.
Sage Therapeutics to Participate in Leerink Investor Conference
Friday, September 22nd 2017 at 8:05pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat...
View ArticleClik here to view.
Verastem to Present at the Cantor Fitzgerald Global Healthcare Conference
Friday, September 22nd 2017 at 11:15am UTC BOSTON–(BUSINESS WIRE)– Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer, today announced that the company will...
View Article
